Tetta C, Camussi G, Turello E, Salomone M, Aimo G, Priolo G, Segoloni G, Vercellone A
Laboratorio di Immunopatologia, Ospedale Molinette, Torino, Italia.
Blood Purif. 1990;8(6):337-46. doi: 10.1159/000169988.
Tumor necrosis factor (TNF-alpha) and interleukin-1 (IL-1 beta) are cytokines primarily produced by monocytes/macrophages when stimulated by endotoxin, complement-derived anaphylatoxins and the specific antigen. In the present study, the plasma levels of TNF-alpha and IL-1 beta were evaluated before and after hemodialysis with cuprophane membrane (in 9 patients) and hemodiafiltration (in 9 patients) using three high-permeability membranes such as polymethylmethacrylate, polyacrylonitrile (AN-69) and polysulfone. In vitro spontaneous production of TNF-alpha and IL-1 beta was evaluated in the supernatants from short-term cultured monocytes obtained before and after treatment. The predialytic levels of TNF-alpha and IL-1 beta were significantly higher (p less than 0.05) in the uremic population than in 21 healthy subjects taken as controls. The analysis of the uremic population regarding the mode of therapy indicated that in hemodialysis the predialytic plasma levels of TNF-alpha and IL-1 beta did not significantly differ from those of healthy subjects. In contrast, in hemodiafiltration with polymethylmethacrylate and AN-69, but not with polysulfone, the predialytic plasma levels of both cytokines were significantly (p less than 0.05) increased. No significant variation in plasma levels of both cytokines was observed after hemodialysis with cuprophane membranes. Hemodiafiltration with polymethylmethacrylate and AN-69, but not with polysulfone, brought about a consistent reduction in plasma levels of both cytokines. Detectable amounts of TNF-alpha and IL-1 beta were spontaneously produced by peripheral-blood monocytes 6 h after the end of hemodialysis but not of hemodiafiltration. These studies suggest a possible role of TNF-alpha and IL-1 beta in the biocompatibility of different extracorporeal treatments.
肿瘤坏死因子(TNF-α)和白细胞介素-1(IL-1β)是单核细胞/巨噬细胞在内毒素、补体衍生的过敏毒素和特异性抗原刺激下主要产生的细胞因子。在本研究中,使用三种高通透性膜,如聚甲基丙烯酸甲酯、聚丙烯腈(AN-69)和聚砜,对9例使用铜仿膜进行血液透析的患者和9例进行血液透析滤过的患者在透析前后的血浆TNF-α和IL-1β水平进行了评估。对治疗前后获得的短期培养单核细胞的上清液进行体外TNF-α和IL-1β自发产生的评估。尿毒症患者透析前的TNF-α和IL-1β水平显著高于作为对照的21名健康受试者(p<0.05)。对尿毒症患者治疗方式的分析表明,血液透析时透析前血浆TNF-α和IL-1β水平与健康受试者无显著差异。相比之下,在使用聚甲基丙烯酸甲酯和AN-69进行血液透析滤过而非聚砜时,两种细胞因子的透析前血浆水平均显著升高(p<0.05)。使用铜仿膜进行血液透析后,两种细胞因子的血浆水平未观察到显著变化。使用聚甲基丙烯酸甲酯和AN-69进行血液透析滤过而非聚砜,可使两种细胞因子的血浆水平持续降低。血液透析结束后6小时,外周血单核细胞可自发产生可检测量的TNF-α和IL-1β,但血液透析滤过结束后则不会。这些研究表明TNF-α和IL-1β在不同体外治疗的生物相容性中可能发挥作用。